gogo
Amazon cover image
Image from Amazon.com

State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization. Volume 2, Biopharmaceutical characterization / edited by John E. Schiel, Darryl L. Davis, Oleg V. Borisov.

Contributor(s): Material type: TextTextSeries: ACS symposium series ; 1201 | State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization ; v. 2Publisher: Washington, DC : American Chemical Society 2104Description: 448 pages : illustrations ; 23 cmISBN:
  • 9780841230293 (hbk.) :
  • 0841230293
Other title:
  • Biopharmaceutical characterization
Subject(s): DDC classification:
  • 616.0798 SCH
LOC classification:
  • QR186.85 .S73 2016
Contents:
1.Determination of the NIST mAB primary structure. Trina Formolo ... [et al] -- 2.Sequence varianst and sequence variant analysis in biotherapeutic protins. Oleg V. Borisov ... [et al] -- 3.Structural elucidation of post-translational modifications in monoclonal antibodies. Wenzhou Li ... [et al] -- 4.Orthogonal technologies for NIST mAB N-Glycan structure elucidation and quantitation. Justin M. Prien ... [et al] -- 5.Separation methods and orthogonal techniques. David A. Michels ... [et al] -- 6.Biophysical techniques for characterizing the higher order structure and interactions of monoclonal antibodies. Yatin Gokarn ... [et al] -- 7.Developability assessment of a proposed INST monoclonal antibody.Dorina Saro ... [et al] -- 8.Protein particles (0.01 æm, 0.01 æm. Dean C. Ripple and Linda O. Narhi -- 9.Analytical methods for the measurement of host cell proteins and other process-related impurities. Kesh Prakahs and Weibin Chen.
Summary: This volume looks at the characterisation of monoclonal antibodies (mAbs), focusing both on general aspects, techniques and regulatory concerns common to any recombinant protein as well as specific analytical results. It therefore serves as both a foundational body of NISTmAb product knowledge as well as an evaluation of its suitability as an industry-appropriate reference material.
Holdings
Item type Current library Call number Status Date due Barcode
Long Loan TUS: Midlands, Main Library Athlone General Lending 616.0798 SCH (Browse shelf(Opens below)) Available 223872

Includes bibliographical references and index.

1.Determination of the NIST mAB primary structure. Trina Formolo ... [et al] -- 2.Sequence varianst and sequence variant analysis in biotherapeutic protins. Oleg V. Borisov ... [et al] -- 3.Structural elucidation of post-translational modifications in monoclonal antibodies. Wenzhou Li ... [et al] -- 4.Orthogonal technologies for NIST mAB N-Glycan structure elucidation and quantitation. Justin M. Prien ... [et al] -- 5.Separation methods and orthogonal techniques. David A. Michels ... [et al] -- 6.Biophysical techniques for characterizing the higher order structure and interactions of monoclonal antibodies. Yatin Gokarn ... [et al] -- 7.Developability assessment of a proposed INST monoclonal antibody.Dorina Saro ... [et al] -- 8.Protein particles (0.01 æm, 0.01 æm. Dean C. Ripple and Linda O. Narhi -- 9.Analytical methods for the measurement of host cell proteins and other process-related impurities. Kesh Prakahs and Weibin Chen.

This volume looks at the characterisation of monoclonal antibodies (mAbs), focusing both on general aspects, techniques and regulatory concerns common to any recombinant protein as well as specific analytical results. It therefore serves as both a foundational body of NISTmAb product knowledge as well as an evaluation of its suitability as an industry-appropriate reference material.

Powered by Koha